• 1599 Citations
  • 24 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Chengji Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Medicine & Life Sciences
Catenins Medicine & Life Sciences
Rats Chemical Compounds
Wnt Signaling Pathway Medicine & Life Sciences
Pituitary Adenylate Cyclase-Activating Polypeptide Medicine & Life Sciences
Brain Medicine & Life Sciences
Oligodendroglia Medicine & Life Sciences
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2016

Research Output 1998 2019

  • 1599 Citations
  • 24 h-Index
  • 47 Article
  • 1 Review article

Impaired neurodevelopmental pathways in autism spectrum disorder: A review of signaling mechanisms and crosstalk

Kumar, S., Reynolds, K., Ji, Y., Gu, R., Rai, S. & Zhou, C., Jun 15 2019, In : Journal of Neurodevelopmental Disorders. 11, 1, 10.

Research output: Contribution to journalReview article

Open Access
Ubiquitin-Protein Ligases
Autism Spectrum Disorder
Genetic Models

In Vivo Genetic Strategies for the Specific Lineage Tracing of Stem Cells

Fan, H., Liu, X., Shen, Y., Chen, S., Huan, Y., Shan, J., Zhou, C., Wu, S., Zhang, Z. & Wang, Y., Jan 1 2019, In : Current stem cell research & therapy. 14, 3, p. 230-238 9 p.

Research output: Contribution to journalArticle

Stem Cells
Stem Cell Niche
1 Citation (Scopus)

Wnt signaling in orofacial clefts: Crosstalk, pathogenesis and models

Reynolds, K., Kumari, P., Rincon, L. S., Gu, R., Ji, Y., Kumar, S. & Zhou, C., Feb 1 2019, In : DMM Disease Models and Mechanisms. 12, 2, dmm037051.

Research output: Contribution to journalArticle

Open Access
Cleft Lip
2 Citations (Scopus)
Spinal Cord Injuries
Chemical activation
9 Citations (Scopus)

Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity

Huang, C., Chen, Y., Liu, H., Yang, J., Song, X., Zhao, J., He, N., Zhou, C., Wang, Y., Huang, C. & Dong, Q., Jan 1 2017, In : Oncotarget. 8, 70, p. 115254-115269 16 p.

Research output: Contribution to journalArticle

Wnt Signaling Pathway
Neoplastic Stem Cells
Breast Neoplasms